Ocugen Inc (OCGN)

Ocugen Inc (OCGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $265M; returns 1 day -6.4%, 1 week -5.2%, 1 year -51.7%.

Ocugen, Inc. is a clinical-stage biopharmaceutical company specializing in the development and commercialization of novel gene therapies aimed at curing blindness diseases. The company's core technology is a 'modifier gene therapy platform' designed to address a wide range of debilitating eye diseases with a single product.

Groups OCGN belongs to

• Biotechnology
• Gene Therapy
• Ophthalmology
• Clinical Stage Biotech
• Rare Diseases
• Clinical Stage
• Biopharmaceutical
• Healthcare
• Life Sciences

OCGN financial model: income statement, cash flow and balance sheet